The latest data, presented at VIVA and The VEINS

Physicians and researchers presented groundbreaking findings from late-breaking clinical trials, follow-up data from major randomized trials and registries, and first-in-man experiences with novel devices or drugs. Each presentation was followed by a discussion and Q&A with a panel of expert faculty.

Click here to read all 5 official press releases.

The 2024 abstract submission portal will open in June.

Abstracts will be evaluated and scored based on the following criteria:

  • Interest to field
  • Research methods
  • Quality of data
  • Primary endpoint presented

Accepted late-breaking clinical trials will be presented:

  • Sunday, November 3 (The VEINS)
  • Monday, November 4 (VIVA)
  • Tuesday, November 5 (VIVA)